NewsWhore
01-20-2012, 12:11 AM
Shares of both companies fell more than 2 percent. The Food and Drug Administration decision Thursday comes after expert FDA advisers in July recommended that dapagliflozin not be approved. They ...
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/202795206/)
More... (http://story.argentinastar.com/index.php/ct/9/cid/d9ed072d737073b4/id/202795206/)